AN INCREMENTAL-DOSE COMBINED OESTROGEN-PROGESTOGEN ORAL-CONTRACEPTIVE - EFFECTS ON BODY-WEIGHT, BLOOD-PRESSURE, AND BIOCHEMICAL PARAMETERS

被引:3
作者
KHOO, SK [1 ]
HACKER, N [1 ]
CHANG, A [1 ]
机构
[1] UNIV QUEENSLAND,WOMENS HOSP,BRISBANE,QLD 4029,AUSTRALIA
关键词
D O I
10.1111/j.1479-828X.1980.tb02901.x
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
引用
收藏
页码:172 / 176
页数:5
相关论文
共 11 条
[1]  
BRIGGS M, 1974, MED J AUSTRALIA, V2, P714
[2]  
BRIGGS MH, 1977, CURR MED RES OPIN, V5, P212
[3]   NEW COMBINED ORAL-CONTRACEPTIVE WITH INCREMENTAL PROGESTOGEN DOSAGE REGIMEN [J].
BROSENS, I ;
VANASSCHE, A ;
KONINCKX, P ;
HEYNS, W ;
DEHERTOGH, R .
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1976, 6 (06) :315-318
[4]   OPTIMUM DOSAGE OF AN ORAL-CONTRACEPTIVE - REPORT FROM THE STUDY OF 7 COMBINATIONS OF NORGESTIMATE AND ETHINYL ESTRADIOL [J].
LAWSON, JS ;
YULIANO, SE ;
PASQUALE, SA ;
OSTERMAN, JJ .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1979, 134 (03) :315-320
[5]  
MEADE TW, 1977, LANCET, V2, P948
[6]  
MILLER GJ, 1975, LANCET, V1, P16
[7]   METABOLIC EFFECTS OF ORAL-CONTRACEPTIVES CONTAINING 30 MICROGRAMS AND 50 MICROGRAMS OF ESTROGEN [J].
NASH, AL ;
CORNISH, EJ ;
HAIN, R .
MEDICAL JOURNAL OF AUSTRALIA, 1979, 2 (06) :277-281
[8]   IS PILL SAFE ENOUGH TO CONTINUE USING [J].
VESSEY, MP ;
DOLL, R .
PROCEEDINGS OF THE ROYAL SOCIETY SERIES B-BIOLOGICAL SCIENCES, 1976, 195 (1118) :69-80
[9]  
VONKAULL.E, 1967, AM J CLIN PATHOL, V48, P69
[10]  
WYNN V, 1974, 2ND INT NORG S